NCT00001122View on ClinicalTrials.gov

A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Primary Completion Date

October 31, 2003

Conditions

HIV Infections

Interventions

DRUG

Nelfinavir mesylate

DRUG

Efavirenz

DRUG

Stavudine

DRUG

Didanosine

Trial Locations (2)

75235

Univ of Texas Southwestern Med Ctr, Dallas

92103

UCSD, San Diego

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001122 - A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly | Biotech Hunter | Biotech Hunter